, Tracking Stock Market Picks
Enter Symbol:
Rating: PFE
down 16.00 %

Pfizer, Inc. (NYSE: PFE) upgraded to Neutral by Sun Trust Rbsn Humphrey

Wednesday,  Nov 25, 2015  10:25 AM ET by Kristen Bailey

The Sun Trust Rbsn Humphrey advised against investing in this stock and the price has fallen for a loss. The price fell from $28.38 on 05/30/2013 to $32.89 on 11/25/2015. Sun
Trust Rbsn Humphrey upgraded Pfizer, Inc. (NYSE: PFE) to Neutral with today's price of $32.89. Sun Trust Rbsn Humphrey rated Pfizer, Inc. (NYSE: PFE) to Reduce on 05/30/2013, when the price was $28.38. Pfizer, Inc.'s stock price gained 16% since then.
By following the previous Sun Trust Rbsn Humphrey's recommendation on PFE, you would have lost 16% in 909 days.

Pfizer Inc is a research-based, global pharmaceutical company that discovers and develops innovative, value-added products that improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. Pfizer has three business segments: health care, animal health and consumer health care. Its products are available in numerous countries. (Company Press Release)

We provide equity research coverage on more than 300 companies in select core industries and sub-sectors with above-average growth potential. Our focused approach allows our analysts to have deep knowledge of industries, companies and markets they cover, enabling them to deliver highly insightful research and sound advice. With our expertise and thoughtful, diligent approach, our equity research positions you to make well-informed decisions that contribute to your success.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy